JT

Juno Therapeutics

Seattle, US

About

Juno is a clinical-stage company that brings together three of the world’s leading cancer centers – Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and Seattle Children’s Research Institute – in unique partnership to advance a broad pipeline of breakthrough immunotherapies. With one of the largest ever Series A investments for a biotech startup, Juno will build on the foundation of novel immunotherapies to develop two distinct and complementary platforms – CARs and TCRs.

Position in the VCSift Database

  • 3,884 investors in VCSift focus on the healthtech sector.
  • 1,032 investors are based in Seattle, Washington, United States.

Data sourced from 410,343 investor profiles. Updated July 2026.

Investment Focus

Location
Seattle, US

Contact Information

In••••@junotherapeutics.com
linkedin.com/in/••••••••

Unlock contact details with a VCSift subscription

Unlock Contact

Already subscribed? Log in

Find more investors like Juno

Search Investors